{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:45:15Z","timestamp":1791945915252,"version":"4.3.4"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03198-1","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T22:45:46Z","timestamp":1754347546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advancements in Liposomal Drug Delivery Systems for Paediatric Neurological Disorders: A Comprehensive Review"],"prefix":"10.1208","volume":"26","author":[{"given":"Parvathy","family":"Hari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa A.","family":"Vahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9824-4788","authenticated-orcid":false,"given":"Vrinda S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"3198_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.24911\/SJP.106-1588669565","volume":"22","author":"O Akodu","year":"2022","unstructured":"Akodu O, Ogunlesi T, Adekanmbi A, Gbadebo F. Neurological diseases at the Pediatric Neurology Clinic in a semi-urban Nigerian tertiary hospital. Sudan J Paediatr. 2022;22:83\u20139.","journal-title":"Sudan J Paediatr"},{"key":"3198_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pediatrneurol.2022.09.005","volume":"138","author":"P Chand","year":"2023","unstructured":"Chand P, Sultan T, Kulsoom S, Jan F, Ibrahim S, Mukhtiar K, et al. Spectrum of Common Pediatric Neurological Disorders: A Cross-Sectional Study From Three Tertiary Care Centres Across Pakistan. Pediatr Neurol. 2023;138:33\u20137.","journal-title":"Pediatr Neurol"},{"key":"3198_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics15112599","volume":"15","author":"SK Niazi","year":"2023","unstructured":"Niazi SK. Non-Invasive Drug Delivery across the Blood-Brain Barrier: A Prospective Analysis. Pharmaceutics. 2023;15:1\u201328.","journal-title":"Pharmaceutics"},{"key":"3198_CR4","doi-asserted-by":"crossref","unstructured":"Boyuklieva R, Pilicheva B. Micro- and nanosized carriers for nose-to-brain drug delivery in neurodegenerative disorders. Biomedicines. 2022;10(7):1706.","DOI":"10.3390\/biomedicines10071706"},{"key":"3198_CR5","first-page":"16","volume":"14","author":"G Kumar","year":"2022","unstructured":"Kumar G, Sharma V, Kumar A. Clinical Profile of Pediatric Neurology Disorders: A Study From a Semi-Urban Medical College in Northwestern India. Cureus. 2022;14:16\u20139.","journal-title":"Cureus"},{"key":"3198_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"Allen TM, Cullis PR. Liposomal drug delivery systems: From concept to clinical applications. Adv Drug Deliv Rev. 2013;65:36\u201348. https:\/\/doi.org\/10.1016\/j.addr.2012.09.037.","journal-title":"Adv Drug Deliv Rev"},{"key":"3198_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","volume":"13","author":"AD Bangham","year":"1965","unstructured":"Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238\u201352.","journal-title":"J Mol Biol"},{"key":"3198_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics8020019","volume":"8","author":"G Gregoriadis","year":"2016","unstructured":"Gregoriadis G. Liposomes in drug delivery: How it all happened. Pharmaceutics. 2016;8:1\u20135.","journal-title":"Pharmaceutics"},{"key":"3198_CR9","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/molecules27041372","volume":"27","author":"P Liu","year":"2022","unstructured":"Liu P, Chen G, Zhang J. A Review of Liposomes as a Drug Delivery System\u202f: Current. Molecules. 2022;27:1372.","journal-title":"Molecules"},{"key":"3198_CR10","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.2147\/IJN.S117210","volume":"11","author":"DB Vieira","year":"2016","unstructured":"Vieira DB, Gamarra LF. Getting into the brain: Liposome-based strategies for effective drug delivery across the blood\u2013brain barrier. Int J Nanomed. 2016;11:5381\u2013414.","journal-title":"Int J Nanomed"},{"key":"3198_CR11","doi-asserted-by":"crossref","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood\u2013brain barrier: Structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8(1):217.","DOI":"10.1038\/s41392-023-01481-w"},{"key":"3198_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.reprotox.2017.06.043","volume":"72","author":"G Schmitt","year":"2017","unstructured":"Schmitt G, Parrott N, Prinssen E, Barrow P. The great barrier belief: The blood\u2013brain barrier and considerations for juvenile toxicity studies. Reprod Toxicol. 2017;72:129\u201335. https:\/\/doi.org\/10.1016\/j.reprotox.2017.06.043.","journal-title":"Reprod Toxicol"},{"key":"3198_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00418-012-1001-9","volume":"138","author":"I Kratzer","year":"2012","unstructured":"Kratzer I, Vasiljevic A, Rey C, Fevre-Montange M, Saunders N, Strazielle N, et al. Complexity and developmental changes in the expression pattern of claudins at the blood-CSF barrier. Histochem Cell Biol. 2012;138:861\u201379.","journal-title":"Histochem Cell Biol"},{"key":"3198_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-021-00240-9","volume":"18","author":"EA Andersson","year":"2021","unstructured":"Andersson EA, Mallard C, Ek CJ. Circulating tight-junction proteins are potential biomarkers for blood\u2013brain barrier function in a model of neonatal hypoxic\/ischemic brain injury. Fluids Barriers CNS. 2021;18:1\u201314. https:\/\/doi.org\/10.1186\/s12987-021-00240-9.","journal-title":"Fluids Barriers CNS"},{"issue":"MAR","key":"3198_CR15","first-page":"1","volume":"3","author":"NR Saunders","year":"2012","unstructured":"Saunders NR, Liddelow SA, Dziegielewska KM. Barrier mechanisms in the developing brain. Front Pharmacol. 2012;3(MAR):1\u201318.","journal-title":"Front Pharmacol"},{"key":"3198_CR16","doi-asserted-by":"crossref","unstructured":"Juhairiyah F, de Lange ECM. Understanding drug delivery to the brain using liposome-based strategies: Studies that provide mechanistic insights are essential. AAPS J. 2021;23(6):114.","DOI":"10.1208\/s12248-021-00648-z"},{"key":"3198_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28\u201351. https:\/\/doi.org\/10.1016\/j.addr.2015.09.012.","journal-title":"Adv Drug Deliv Rev"},{"key":"3198_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.colsurfb.2018.09.047","volume":"173","author":"S Lakkadwala","year":"2019","unstructured":"Lakkadwala S, Singh J. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model. Colloids Surfaces B Biointerfaces. 2019;173:27\u201335. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.09.047.","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"3198_CR19","doi-asserted-by":"publisher","first-page":"28240","DOI":"10.1021\/jacs.3c11463","volume":"145","author":"A Scheeder","year":"2023","unstructured":"Scheeder A, Brockhoff M, Ward EN, Kaminski Schierle GS, Mela I, Kaminski CF. Molecular Mechanisms of Cationic Fusogenic Liposome Interactions with Bacterial Envelopes. J Am Chem Soc. 2023;145:28240\u201350.","journal-title":"J Am Chem Soc"},{"key":"3198_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/nop\/npy037","volume":"6","author":"CL Nesvick","year":"2019","unstructured":"Nesvick CL, Nageswara Rao AA, Raghunathan A, Biegel JA, Daniels DJ. Case-based review: Atypical teratoid\/rhabdoid tumor. Neuro-Oncology Pract. 2019;6:163\u201378.","journal-title":"Neuro-Oncology Pract"},{"key":"3198_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/MPH.0b013e318041f112","volume":"29","author":"M Benesch","year":"2007","unstructured":"Benesch M, Sovinz P, Krammer B, Lackner H, Mann G, Schwinger W, et al. Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis. J Pediatr Hematol Oncol. 2007;29:222\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"3198_CR22","doi-asserted-by":"publisher","unstructured":"National Research Council (US) and Institute of Medicine (US) Committee on Integrating the Science of Early Childhood Development. From neurons to neighborhoods: The science of early childhood development. In: Jack P. Shonkoff et. al., editors. National Academies Press (US), 2000. https:\/\/doi.org\/10.17226\/9824.","DOI":"10.17226\/9824"},{"key":"3198_CR23","unstructured":"Tierney AL, Nelson CA. Brain Development and the Role of Experience in the Early Years. Zero Three [Internet]. 2009;30:9\u201313. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23894221\/0A,\u00a0http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC3722610,\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3722610\/. Accessed 18 Jul 2025."},{"key":"3198_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrn.2018.1","volume":"19","author":"JH Gilmore","year":"2018","unstructured":"Gilmore JH, Knickmeyer RC, Gao W. Imaging structural and functional brain development in early childhood. Nat Rev Neurosci. 2018;19:123\u201337. https:\/\/doi.org\/10.1038\/nrn.2018.1.","journal-title":"Nat Rev Neurosci"},{"key":"3198_CR25","doi-asserted-by":"crossref","unstructured":"Marzola P, Melzer T, Pavesi E, Gil-Mohapel J, Brocardo PS. Exploring the Role of neuroplasticity in development, aging, and neurodegeneration. Brain Sci. 2023;13(12):1610.","DOI":"10.3390\/brainsci13121610"},{"key":"3198_CR26","first-page":"1233","volume":"47","author":"A Manuscript","year":"2009","unstructured":"Manuscript A. Neuroimaging Studies of Human Brain. October. 2009;47:1233\u201351.","journal-title":"October"},{"key":"3198_CR27","doi-asserted-by":"publisher","first-page":"16096","DOI":"10.1073\/pnas.2010281117","volume":"117","author":"J Sakai","year":"2020","unstructured":"Sakai J. How synaptic pruning shapes neural wiring during development and possibly, in disease. Proc Natl Acad Sci U S A. 2020;117:16096\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3198_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","volume":"3","author":"E Fernandez","year":"2011","unstructured":"Fernandez E, Perez R, Hernandez A, Tejada P, Arteta M, Ramos JT. Factors and mechanisms for pharmacokinetic differences between pediatrie population and adults. Pharmaceutics. 2011;3:53\u201372.","journal-title":"Pharmaceutics"},{"key":"3198_CR29","doi-asserted-by":"crossref","unstructured":"Hersh AM, Alomari S, Tyler BM. Crossing the blood-brain barrier: Advances in nanoparticle technology for drug delivery in neuro-oncology. Int J Mol Sci. 2022;23(8):4153.","DOI":"10.3390\/ijms23084153"},{"key":"3198_CR30","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.2147\/DDDT.S218708","volume":"13","author":"S Bagchi","year":"2019","unstructured":"Bagchi S, Chhibber T, Lahooti B, Verma A, Borse V, Jayant RD. In-vitro blood-brain barrier models for drug screening and permeation studies: An overview. Drug Des Devel Ther. 2019;13:3591\u2013605.","journal-title":"Drug Des Devel Ther"},{"key":"3198_CR31","first-page":"1","volume":"23","author":"J Bailey","year":"2013","unstructured":"Bailey J, Oliveri A. Levin E. \u57fa\u56e0\u7684\u6539\u53d8NIH Public Access. Bone. 2013;23:1\u20137.","journal-title":"Bone"},{"key":"3198_CR32","doi-asserted-by":"crossref","unstructured":"Song J, Lu C, Leszek J, Zhang J. Design and development of nanomaterial-based drug carriers to overcome the blood\u2013brain barrier by using different transport mechanisms. Int J Mol Sci. 2021;22(18):10118.","DOI":"10.3390\/ijms221810118"},{"key":"3198_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.21873\/anticanres.13103","volume":"39","author":"B Yuan","year":"2019","unstructured":"Yuan B, Zhao Y, Dong S, Sun Y, Hao F, Xie J, et al. Cell-penetrating peptide-coated liposomes for drug delivery across the blood-brain barrier. Anticancer Res. 2019;39:237\u201343.","journal-title":"Anticancer Res"},{"key":"3198_CR34","doi-asserted-by":"publisher","first-page":"101665","DOI":"10.1016\/j.pneurobio.2019.101665","volume":"181","author":"KB Johnsen","year":"2019","unstructured":"Johnsen KB, Burkhart A, Thomsen LB, Andresen TL, Moos T. Targeting the transferrin receptor for brain drug delivery. Prog Neurobiol. 2019;181:101665. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101665.","journal-title":"Prog Neurobiol"},{"key":"3198_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-01048-3","volume":"19","author":"J Li","year":"2021","unstructured":"Li J, Zeng H, You Y, Wang R, Tan T, Wang W, et al. Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin. J Nanobiotechnology. 2021;19:1\u201319. https:\/\/doi.org\/10.1186\/s12951-021-01048-3.","journal-title":"J Nanobiotechnology"},{"key":"3198_CR36","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s11095-021-03098-6","volume":"38","author":"EM Rhea","year":"2021","unstructured":"Rhea EM, Banks WA. Interactions of Lipids, Lipoproteins, and Apolipoproteins with the Blood-Brain Barrier. Pharm Res. 2021;38:1469\u201375.","journal-title":"Pharm Res"},{"key":"3198_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejps.2011.07.007","volume":"44","author":"H Chen","year":"2011","unstructured":"Chen H, Qin Y, Zhang Q, Jiang W, Tang L, Liu J, et al. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas. Eur J Pharm Sci. 2011;44:164\u201373. https:\/\/doi.org\/10.1016\/j.ejps.2011.07.007.","journal-title":"Eur J Pharm Sci"},{"key":"3198_CR38","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.1016\/j.biomaterials.2014.03.082","volume":"35","author":"YC Kuo","year":"2014","unstructured":"Kuo YC, Wang CT. Protection of SK-N-MC cells against \u03b2-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrin. Biomaterials. 2014;35:5954\u201364. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.03.082.","journal-title":"Biomaterials"},{"key":"3198_CR39","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.2147\/IJN.S132472","volume":"12","author":"YC Kuo","year":"2017","unstructured":"Kuo YC, Tsao CW. Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin. Int J Nanomedicine. 2017;12:2857\u201369.","journal-title":"Int J Nanomedicine"},{"key":"3198_CR40","doi-asserted-by":"crossref","unstructured":"Loureiro JA, Gomes B, Coelho MA, Do Carmo Pereira M, Rocha S. Immunoliposomes doubly targeted to transferrin receptor and to \u03b1-synuclein. Futur Sci OA. 2015;1(4):FSO71.","DOI":"10.4155\/fso.15.71"},{"key":"3198_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jconrel.2017.11.026","volume":"269","author":"JS Kim","year":"2018","unstructured":"Kim JS, Shin DH, Kim JS. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells. J Control Release. 2018;269:245\u201357. https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.026.","journal-title":"J Control Release"},{"key":"3198_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12113211","volume":"12","author":"G Jose","year":"2020","unstructured":"Jose G, Lu YJ, Hung JT, Yu AL, Chen JP. Co-delivery of cpt-11 and panobinostat with anti-gd2 antibody conjugated immunoliposomes for targeted combination chemotherapy. Cancers (Basel). 2020;12:1\u201325.","journal-title":"Cancers (Basel)"},{"key":"3198_CR43","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.2147\/IJN.S241055","volume":"15","author":"N Grafals-Ruiz","year":"2020","unstructured":"Grafals-Ruiz N, Rios-Vicil CI, Lozada-Delgado EL, Qui\u00f1ones-D\u00edaz BI, Noriega-Rivera RA, Mart\u00ednez-Zayas G, et al. Brain targeted gold liposomes improve rnai delivery for glioblastoma. Int J Nanomedicine. 2020;15:2809\u201328.","journal-title":"Int J Nanomedicine"},{"key":"3198_CR44","first-page":"4267","volume":"9","author":"M Tamaru","year":"2014","unstructured":"Tamaru M, Akita H, Nakatani T, Kajimoto K, Sato Y, Hatakeyama H, et al. Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain. Int J Nanomed. 2014;9:4267\u201376.","journal-title":"Int J Nanomed"},{"key":"3198_CR45","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1016\/j.biomaterials.2014.02.031","volume":"35","author":"Y Liu","year":"2014","unstructured":"Liu Y, Ran R, Chen J, Kuang Q, Tang J, Mei L, et al. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Biomater. 2014;35:4835\u201347. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.02.031.","journal-title":"Biomater"},{"key":"3198_CR46","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.3390\/molecules24193540","volume":"24","author":"X Wang","year":"2019","unstructured":"Wang X, Zhao Y, Dong S, Lee RJ, Yang D, Zhang H, et al. Liposomes for Targeted Therapy of Glioma. Mol. 2019;24:3540.","journal-title":"Mol"},{"key":"3198_CR47","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.eplepsyres.2014.01.010","volume":"108","author":"L Holtman","year":"2014","unstructured":"Holtman L, Van Vliet EA, Appeldoorn C, Gaillard PJ, De Boer M, Dorland R, et al. Glutathione pegylated liposomal methylprednisolone administration after the early phase of status epilepticus did not modify epileptogenesis in the rat. Epilepsy Res. 2014;108:396\u2013404. https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.01.010.","journal-title":"Epilepsy Res"},{"key":"3198_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejpb.2019.04.004","volume":"139","author":"Y Hu","year":"2019","unstructured":"Hu Y, Gaillard PJ, de Lange ECM, Hammarlund-Udenaes M. Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference? Eur J Pharm Biopharm. 2019;139:197\u2013204. https:\/\/doi.org\/10.1016\/j.ejpb.2019.04.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"3198_CR49","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1016\/j.biomaterials.2013.03.097","volume":"34","author":"JQ Gao","year":"2013","unstructured":"Gao JQ, Lv Q, Li LM, Tang XJ, Li FZ, Hu YL, et al. Glioma targeting and blood-brain barrier penetration bydual-targeting doxorubincin liposomes. Biomaterials. 2013;34:5628\u201339. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.03.097.","journal-title":"Biomaterials"},{"key":"3198_CR50","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejps.2018.07.055","volume":"124","author":"M Li","year":"2018","unstructured":"Li M, Shi K, Tang X, Wei J, Cun X, Chen X, et al. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma. Eur J Pharm Sci. 2018;124:240\u20138. https:\/\/doi.org\/10.1016\/j.ejps.2018.07.055.","journal-title":"Eur J Pharm Sci"},{"key":"3198_CR51","doi-asserted-by":"publisher","first-page":"112361","DOI":"10.1016\/j.msec.2021.112361","volume":"129","author":"YC Kuo","year":"2021","unstructured":"Kuo YC, Chen IY, Rajesh R. Astragaloside IV- and nesfatin-1-encapsulated phosphatidylserine liposomes conjugated with wheat germ agglutinin and leptin to activate anti-apoptotic pathway and block phosphorylated tau protein expression for Parkinson\u2019s disease treatment. Mater Sci Eng C. 2021;129:112361. https:\/\/doi.org\/10.1016\/j.msec.2021.112361.","journal-title":"Mater Sci Eng C"},{"key":"3198_CR52","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.bbrc.2010.03.024","volume":"394","author":"M Tamaru","year":"2010","unstructured":"Tamaru M, Akita H, Fujiwara T, Kajimoto K, Harashima H. Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis. Biochem Biophys Res Commun. 2010;394:587\u201392. https:\/\/doi.org\/10.1016\/j.bbrc.2010.03.024.","journal-title":"Biochem Biophys Res Commun"},{"key":"3198_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijpharm.2011.07.021","volume":"419","author":"Y Qin","year":"2011","unstructured":"Qin Y, Chen H, Yuan W, Kuai R, Zhang Q, Xie F, et al. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm. 2011;419:85\u201395. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.07.021.","journal-title":"Int J Pharm"},{"key":"3198_CR54","doi-asserted-by":"crossref","unstructured":"Song Y, Huang Q, Pu Q, Ni S, Zhu W, Zhao W, et al. Gastrodin liposomes block crosstalk between astrocytes and glioma cells via downregulating Cx43 to improve antiglioblastoma efficacy of temozolomide. Bioconjug Chem. 2024 ;35(9):1380\u20131390.","DOI":"10.1021\/acs.bioconjchem.4c00300"},{"key":"3198_CR55","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4155\/tde-2023-0044","volume":"14","author":"V Kumar","year":"2023","unstructured":"Kumar V, NK R, Aswin D, Nair SC. Propranolol HCL-loaded liposomes for intranasal delivery: in vitro and ex vivo evaluation of optimized formulation using design of experiments. Ther Deliv. 2023;14:705\u201320.","journal-title":"Ther Deliv"},{"key":"3198_CR56","doi-asserted-by":"crossref","unstructured":"Mellinger A, Lubitz LJ, Gazaille C, Leneweit G, Bastiat G, L\u00e9pinoux-Chambaud C, et al. The use of liposomes functionalized with the NFL-TBS.40\u201363 peptide as a targeting agent to cross the in vitro blood\u2013brain barrier and target glioblastoma cells. Int J Pharm. 2023;646:123421.","DOI":"10.1016\/j.ijpharm.2023.123421"},{"key":"3198_CR57","doi-asserted-by":"publisher","first-page":"344","DOI":"10.5530\/ijpi.2020.3.61","volume":"10","author":"RR Padalkar","year":"2020","unstructured":"Padalkar RR, Madgulkar AR, Bhalekar MR. Brain Targeted Delivery of Rizatriptan using Glutathione Conjugated Liposomes through Transmucosal Nasal Route. Int J Pharm Investig. 2020;10:344\u201350.","journal-title":"Int J Pharm Investig"},{"key":"3198_CR58","doi-asserted-by":"publisher","first-page":"105387","DOI":"10.1016\/j.jddst.2024.105387","volume":"93","author":"JY Cai","year":"2024","unstructured":"Cai JY, Liu Y, Zhang L, Guo RB, Li XT, Ma LY, et al. Menthol-modified paclitaxel multifunctional cationic liposomes cross the blood-brain barrier and target glioma stem cells for treatment of glioblastoma. J Drug Deliv Sci Technol. 2024;93:105387. https:\/\/doi.org\/10.1016\/j.jddst.2024.105387.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3198_CR59","doi-asserted-by":"publisher","first-page":"103674","DOI":"10.1016\/j.jddst.2022.103674","volume":"75","author":"A Najmi","year":"2022","unstructured":"Najmi A, Wang S, Huang Y, Seefeldt T, Alqahtani Y, Guan X. 2-(2-Cholesteroxyethoxyl)ethyl-3\u2032-S-glutathionylpropionate (COXP) for brain-targeting liposomes. J Drug Deliv Sci Technol. 2022;75:103674. https:\/\/doi.org\/10.1016\/j.jddst.2022.103674.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3198_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejps.2016.09.024","volume":"96","author":"XL Song","year":"2017","unstructured":"Song XL, Liu S, Jiang Y, Gu LY, Xiao Y, Wang X. Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain glioma. Eur J Pharm Sci. 2017;96:129\u201340. https:\/\/doi.org\/10.1016\/j.ejps.2016.09.024.","journal-title":"Eur J Pharm Sci"},{"key":"3198_CR61","doi-asserted-by":"publisher","first-page":"111652","DOI":"10.1016\/j.msec.2020.111652","volume":"120","author":"R Sonkar","year":"2021","unstructured":"Sonkar R, Sonali, Jha A, Viswanadh MK, Burande AS, Narendra, et al. Gold liposomes for brain-targeted drug delivery: Formulation and brain distribution kinetics. Mater Sci Eng C. 2021;120:111652. https:\/\/doi.org\/10.1016\/j.msec.2020.111652.","journal-title":"Mater Sci Eng C"},{"key":"3198_CR62","doi-asserted-by":"publisher","first-page":"121608","DOI":"10.1016\/j.biomaterials.2022.121608","volume":"287","author":"M Ismail","year":"2022","unstructured":"Ismail M, Yang W, Li Y, Chai T, Zhang D, Du Q, et al. Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma. Biomaterials. 2022;287:121608. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121608.","journal-title":"Biomaterials"},{"key":"3198_CR63","doi-asserted-by":"publisher","first-page":"116704","DOI":"10.1016\/j.bmc.2022.116704","volume":"60","author":"Z Li","year":"2022","unstructured":"Li Z, Lu J, Tang B, Shi Y, Hai L, Guo L, et al. Triple branched RGD modification on liposomes: A prospective strategy to enhance the glioma targeting efficiency. Bioorganic Med Chem. 2022;60:116704. https:\/\/doi.org\/10.1016\/j.bmc.2022.116704.","journal-title":"Bioorganic Med Chem"},{"key":"3198_CR64","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jconrel.2023.07.030","volume":"360","author":"D Jia","year":"2023","unstructured":"Jia D, Lu Y, Lv M, Wang F, Lu X, Zhu W, et al. Targeted co-delivery of resiquimod and a SIRP\u03b1 variant by liposomes to activate macrophage immune responses for tumor immunotherapy. J Control Release. 2023;360:858\u201371. https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.030.","journal-title":"J Control Release"},{"key":"3198_CR65","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jconrel.2024.07.014","volume":"373","author":"Y Yang","year":"2024","unstructured":"Yang Y, Chu Y, Li C, Fan L, Lu H, Zhan C, et al. Brain-targeted drug delivery by in vivo functionalized liposome with stable D-peptide ligand. J Control Release. 2024;373:240\u201351. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.014.","journal-title":"J Control Release"},{"key":"3198_CR66","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jconrel.2023.02.004","volume":"355","author":"H Li","year":"2023","unstructured":"Li H, Yin D, Liao J, Wang Y, Gou R, Tang C, et al. Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy. J Control Release. 2023;355:593\u2013603. https:\/\/doi.org\/10.1016\/j.jconrel.2023.02.004.","journal-title":"J Control Release"},{"key":"3198_CR67","doi-asserted-by":"publisher","first-page":"41148","DOI":"10.1021\/acsami.0c13372","volume":"12","author":"Y Dai","year":"2020","unstructured":"Dai Y, Song Y, Xie J, Xiao G, Li X, Li Z, et al. CB1-Antibody Modified Liposomes for Targeted Modulation of Epileptiform Activities Synchronously Detected by Microelectrode Arrays. ACS Appl Mater Interfaces. 2020;12:41148\u201356.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3198_CR68","doi-asserted-by":"publisher","first-page":"124862","DOI":"10.1016\/j.colsurfa.2020.124862","volume":"599","author":"MH Chen","year":"2020","unstructured":"Chen MH, Chiang BH. Modification of curcumin-loaded liposome with edible compounds to enhance ability of crossing blood brain barrier. Colloids Surfaces A Physicochem Eng Asp. 2020;599:124862. https:\/\/doi.org\/10.1016\/j.colsurfa.2020.124862.","journal-title":"Colloids Surfaces A Physicochem Eng Asp"},{"key":"3198_CR69","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jad.2023.07.071","volume":"339","author":"G Ayano","year":"2023","unstructured":"Ayano G, Demelash S, Gizachew Y, Tsegay L, Alati R. The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses. J Affect Disord. 2023;339:860\u20136. https:\/\/doi.org\/10.1016\/j.jad.2023.07.071.","journal-title":"J Affect Disord"},{"key":"3198_CR70","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ydbio.2018.03.023","volume":"438","author":"C Dark","year":"2018","unstructured":"Dark C, Homman-Ludiye J, Bryson-Richardson RJ. The role of ADHD associated genes in neurodevelopment. Dev Biol. 2018;438:69\u201383. https:\/\/doi.org\/10.1016\/j.ydbio.2018.03.023.","journal-title":"Dev Biol"},{"key":"3198_CR71","doi-asserted-by":"crossref","unstructured":"Duong VA, Nguyen TTL, Maeng HJ. Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery. Pharmaceutics. 2023;15(1):207.","DOI":"10.3390\/pharmaceutics15010207"},{"key":"3198_CR72","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jconrel.2023.06.005","volume":"359","author":"K Sasaki","year":"2023","unstructured":"Sasaki K, Fukakusa S, Torikai Y, Suzuki C, Sonohata I, Kawahata T, et al. Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys. J Control Release. 2023;359:384\u201399. https:\/\/doi.org\/10.1016\/j.jconrel.2023.06.005.","journal-title":"J Control Release"},{"key":"3198_CR73","first-page":"286","volume":"8","author":"AV Vaidya","year":"2016","unstructured":"Vaidya AV, Shinde UA, Shimpi HH. Preliminary studies on brain targeting of intranasal atomoxetine liposomes. Int J Pharm Pharm Sci. 2016;8:286\u201392.","journal-title":"Int J Pharm Pharm Sci"},{"key":"3198_CR74","first-page":"1","volume":"9","author":"C Tye","year":"2018","unstructured":"Tye C, Runicles AK, Whitehouse AJO, Alvares GA. Characterizing the interplay between autism spectrum disorder and comorbid medical conditions: An integrative review. Front Psychiatry. 2018;9:1\u201321.","journal-title":"Front Psychiatry"},{"key":"3198_CR75","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pharmthera.2018.05.007","volume":"190","author":"SR Sharma","year":"2018","unstructured":"Sharma SR, Gonda X, Tarazi FI. Autism Spectrum Disorder: Classification, diagnosis and therapy. Pharmacol Ther. 2018;190:91\u2013104. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.05.007.","journal-title":"Pharmacol Ther"},{"key":"3198_CR76","doi-asserted-by":"publisher","first-page":"113360","DOI":"10.1016\/j.biopha.2022.113360","volume":"153","author":"A Alhusaini","year":"2022","unstructured":"Alhusaini A, Sarawi W, Mattar D, Abo-Hamad A, Almogren R, Alhumaidan S, et al. Acetyl-L-carnitine and\/or liposomal co-enzyme Q10 prevent propionic acid-induced neurotoxicity by modulating oxidative tissue injury, inflammation, and ALDH1A1-RA-RAR\u03b1 signaling in rats. Biomed Pharmacother. 2022;153:113360. https:\/\/doi.org\/10.1016\/j.biopha.2022.113360.","journal-title":"Biomed Pharmacother"},{"key":"3198_CR77","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","volume":"72","author":"W L\u00f6scher","year":"2020","unstructured":"L\u00f6scher W, Potschka H, Sisodiya SM, Vezzani A. Drug resistance in epilepsy: Clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev. 2020;72:606\u201338.","journal-title":"Pharmacol Rev"},{"key":"3198_CR78","doi-asserted-by":"crossref","unstructured":"Adiga SH, Adiga RS, Bhat KMR, Upadhya D. Ayurveda therapy in the management of epilepsy. Epilepsy Behav. 2024;159:110026.","DOI":"10.1016\/j.yebeh.2024.110026"},{"key":"3198_CR79","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2174\/157015909788848857","volume":"7","author":"E St Louis","year":"2009","unstructured":"St Louis E. Minimizing AED Adverse Effects: Improving Quality of Life in the Interictal State in Epilepsy Care. Curr Neuropharmacol. 2009;7:106\u201314.","journal-title":"Curr Neuropharmacol"},{"key":"3198_CR80","doi-asserted-by":"publisher","unstructured":"Kumar VS, Vinayan K, Sabitha M. Anticonvulsant and acute toxicity evaluation of phenytoin sodium\u2013loaded polymeric nanomicelle in MES rat model. J Nanoparticle Res [Internet]. 2022;24. Available from: https:\/\/doi.org\/10.1007\/s11051-022-05502-7","DOI":"10.1007\/s11051-022-05502-7"},{"key":"3198_CR81","doi-asserted-by":"publisher","first-page":"72","DOI":"10.14581\/jer.21010","volume":"11","author":"J-S Sunwoo","year":"2021","unstructured":"Sunwoo J-S, Jo H, Kang KW, Kim KT, Kim D, Kim DW, et al. Survey on Antiepileptic Drug Therapy in Patients with Drug Resistant Epilepsy. J Epilepsy Res. 2021;11:72\u201382.","journal-title":"J Epilepsy Res"},{"key":"3198_CR82","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/ipd.12432","volume":"29","author":"HI Morgan","year":"2019","unstructured":"Morgan HI, Abou El Fadl RK, Kabil NS, Elagouza I. Assessment of oral health status of children with epilepsy: A retrospective cohort study. Int J Paediatr Dent. 2019;29:79\u201385.","journal-title":"Int J Paediatr Dent"},{"key":"3198_CR83","doi-asserted-by":"publisher","first-page":"105636","DOI":"10.1016\/j.phrs.2021.105636","volume":"169","author":"A Taleb","year":"2021","unstructured":"Taleb A, Zhou YP, Meng LT, Zhu MY, Zhang Q, Naveed M, et al. New application of an old drug proparacaine in treating epilepsy via liposomal hydrogel formulation. Pharmacol Res. 2021;169:105636. https:\/\/doi.org\/10.1016\/j.phrs.2021.105636.","journal-title":"Pharmacol Res"},{"key":"3198_CR84","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1472-8206.2011.01002.x","volume":"27","author":"NB Agarwal","year":"2013","unstructured":"Agarwal NB, Jain S, Nagpal D, Agarwal NK, Mediratta PK, Sharma KK. Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice. Fundam Clin Pharmacol. 2013;27:169\u201372.","journal-title":"Fundam Clin Pharmacol"},{"key":"3198_CR85","doi-asserted-by":"publisher","first-page":"e09030","DOI":"10.1016\/j.heliyon.2022.e09030","volume":"8","author":"M Jufri","year":"2022","unstructured":"Jufri M, Yuwanda A, Surini S, Harahap Y. Study of valproic acid liposomes for delivery into the brain through an intranasal route. Heliyon. 2022;8:e09030. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09030.","journal-title":"Heliyon"},{"key":"3198_CR86","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuroscience.2017.05.026","volume":"357","author":"MS Ethemoglu","year":"2017","unstructured":"Ethemoglu MS, Seker FB, Akkaya H, Kilic E, Aslan I, Erdogan CS, et al. Anticonvulsant activity of resveratrol-loaded liposomes in vivo. Neurosci. 2017;357:12\u20139. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.05.026.","journal-title":"Neurosci"},{"key":"3198_CR87","doi-asserted-by":"publisher","unstructured":"Praveen A, Aqil M, Imam SS, Ahad A, Moolakkadath T, Ahmad FJ. Lamotrigine encapsulated intra-nasal nanoliposome formulation for epilepsy treatment: Formulation design, characterization and nasal toxicity study. Colloids Surfaces B Biointerfaces [Internet]. 2019;174:553\u201362. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.11.025. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0927776518308014","DOI":"10.1016\/j.colsurfb.2018.11.025"},{"key":"3198_CR88","doi-asserted-by":"crossref","first-page":"247","DOI":"10.22159\/ijpps.2016v8i11.13861","volume":"8","author":"D Nagpal","year":"2016","unstructured":"Nagpal D, Agarwal N, Katare D. Evaluation of liposomal gossypin in animal models of epilepsy. Int J Pharm Pharm Sci. 2016;8:247\u201351.","journal-title":"Int J Pharm Pharm Sci"},{"key":"3198_CR89","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/dmcn.12679","volume":"57","author":"V Raieli","year":"2015","unstructured":"Raieli V, Pitino R, Giordano G, Spitalieri C, Consolo F, Puma D, et al. Migraine in a pediatric population: A clinical study in children younger than 7 years of age. Dev Med Child Neurol. 2015;57:585\u20138.","journal-title":"Dev Med Child Neurol"},{"key":"3198_CR90","first-page":"37","volume":"27","author":"F Alharbi","year":"2020","unstructured":"Alharbi F, Alateeq M. Quality of life of migraine patients followed in neurology clinics in Riyadh. Saudi Arabia J Fam Community Med. 2020;27:37\u201345.","journal-title":"Saudi Arabia J Fam Community Med"},{"key":"3198_CR91","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1001\/jama.2018.4853","volume":"319","author":"DW Dodick","year":"2018","unstructured":"Dodick DW, Silberstein SD, Bigal ME, Yeung PP, Goadsby PJ, Blankenbiller T, et al. Effect of Fremanezumab compared with placebo for prevention of episodic migraine a randomized clinical trial. JAMA - J Am Med Assoc. 2018;319:1999\u20132008.","journal-title":"JAMA - J Am Med Assoc"},{"key":"3198_CR92","doi-asserted-by":"crossref","unstructured":"Alwhaibi M, Balkhi B, AlRuthia Y. Anxiety and depression and health-related quality of life among adults with migraine: A national population-based study. Front Public Heal. 2023;11:1241800.","DOI":"10.3389\/fpubh.2023.1241800"},{"key":"3198_CR93","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2165\/11317540-000000000-00000","volume":"24","author":"AM Rapoport","year":"2010","unstructured":"Rapoport AM, Freitag F, Pearlman SH. Innovative Delivery Systems for Migraine. CNS Drugs. 2010;24:929\u201340. https:\/\/doi.org\/10.2165\/11317540-000000000-00000.","journal-title":"CNS Drugs"},{"key":"3198_CR94","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0972753120929563","volume":"27","author":"R Pradeep","year":"2020","unstructured":"Pradeep R, Nemichandra SC, Harsha S, Radhika K. Migraine disability, quality of life, and its predictors. Ann Neurosci.\u00a02020; 27 (1):18\u201323.","journal-title":"Ann Neurosci"},{"key":"3198_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.800605","volume":"12","author":"P Amiri","year":"2022","unstructured":"Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M, et al. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol. 2022;12:1\u201315.","journal-title":"Front Neurol"},{"key":"3198_CR96","first-page":"90","volume":"13","author":"S Assadpour","year":"2022","unstructured":"Assadpour S, Akhtari J, Shiran MR. Pharmacokinetics study of chitosan-coated liposomes containing sumatriptan in the treatment of migraine. Casp J Intern Med. 2022;13:90\u20139.","journal-title":"Casp J Intern Med"},{"key":"3198_CR97","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2147\/IJN.S162087","volume":"13","author":"AE Bulboac\u0103","year":"2018","unstructured":"Bulboac\u0103 AE, Bolboac\u0103 SD, St\u0103nescu IC, Sfr\u00e2ngeu CA, Porfire A, Tefas L, et al. The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats. Int J Nanomedicine. 2018;13:3093\u2013103.","journal-title":"Int J Nanomedicine"},{"key":"3198_CR98","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1208\/s12249-013-9924-6","volume":"14","author":"C Sun","year":"2013","unstructured":"Sun C, Wang J, Liu J, Qiu L, Zhang W, Zhang L. Liquid proliposomes of nimodipine drug delivery system: Preparation, characterization, and pharmacokinetics. AAPS PharmSciTech. 2013;14:332\u20138.","journal-title":"AAPS PharmSciTech"},{"key":"3198_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-023-02679-5","volume":"24","author":"L Ma","year":"2023","unstructured":"Ma L, Mao HY, Xu J, Piao J, Piao M. Study on the Nasal Drug Delivery System of NMD Liposomes In Situ Thermosensitive Gel. AAPS PharmSciTech. 2023;24:1\u201316. https:\/\/doi.org\/10.1208\/s12249-023-02679-5.","journal-title":"AAPS PharmSciTech"},{"key":"3198_CR100","doi-asserted-by":"crossref","unstructured":"Pollack IF, Agnihotri S, Broniscer A. Childhood brain tumors: Current management, biological insights, and future directions. J. Neurosurg. Pediatr. American Association of Neurological Surgeons; 2019; 23(3):261\u2013273.","DOI":"10.3171\/2018.10.PEDS18377"},{"key":"3198_CR101","doi-asserted-by":"publisher","first-page":"722","DOI":"10.21037\/jtd-23-464","volume":"16","author":"F Minervini","year":"2024","unstructured":"Minervini F, Sergi CM, Scarci M, Kestenholz PB, Valentini L, Boschetti L, et al. Benign tumors of the chest wall. J Thorac Dis. 2024;16:722\u201336.","journal-title":"J Thorac Dis"},{"key":"3198_CR102","doi-asserted-by":"publisher","first-page":"116113","DOI":"10.1016\/j.biopha.2023.116113","volume":"171","author":"C Zhao","year":"2024","unstructured":"Zhao C, Zhu X, Tan J, Mei C, Cai X, Kong F. Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment. Biomed Pharmacother. 2024;171:116113. https:\/\/doi.org\/10.1016\/j.biopha.2023.116113.","journal-title":"Biomed Pharmacother"},{"key":"3198_CR103","doi-asserted-by":"crossref","unstructured":"Raju R, Abuwatfa WH, Pitt WG, Husseini GA. Liposomes for the treatment of brain cancer\u2014A review. Pharmaceuticals. 2023;16(8):1056.","DOI":"10.3390\/ph16081056"},{"key":"3198_CR104","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid Nanoparticles from Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. ACS Nano. 2021;15:16982\u20137015.","journal-title":"ACS Nano"},{"key":"3198_CR105","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","volume":"11","author":"L Han","year":"2021","unstructured":"Han L, Jiang C. Evolution of blood\u2013brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharm Sin B. 2021;11:2306\u201325. https:\/\/doi.org\/10.1016\/j.apsb.2020.11.023.","journal-title":"Acta Pharm Sin B"},{"key":"3198_CR106","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3109\/10717544.2016.1162878","volume":"23","author":"Sonali","year":"2016","unstructured":"Sonali, Singh RP, Singh N, Sharma G, Vijayakumar MR, Koch B, et al. Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics. Drug Deliv. 2016;23:1261\u201371.","journal-title":"Drug Deliv"},{"key":"3198_CR107","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.2147\/IJN.S255902","volume":"15","author":"MS Ashrafzadeh","year":"2020","unstructured":"Ashrafzadeh MS, Akbarzadeh A, Heydarinasab A, Ardjmand M. In vivo glioblastoma therapy using targeted liposomal cisplatin. Int J Nanomed. 2020;15:7035\u201349.","journal-title":"Int J Nanomed"},{"key":"3198_CR108","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5582\/ddt.2015.01016","volume":"9","author":"J Gao","year":"2015","unstructured":"Gao J, Wang Z, Liu H, Wang L, Huang G. Liposome encapsulated of temozolomide for the treatment of glioma tumor: preparation, characterization and evaluation. Drug Discov Ther. 2015;9:205\u201312.","journal-title":"Drug Discov Ther"},{"key":"3198_CR109","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1021\/acschemneuro.8b00339","volume":"9","author":"A Arcella","year":"2018","unstructured":"Arcella A, Palchetti S, Digiacomo L, Pozzi D, Capriotti AL, Frati L, et al. Brain Targeting by Liposome-Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells. ACS Chem Neurosci. 2018;9:3166\u201374.","journal-title":"ACS Chem Neurosci"},{"key":"3198_CR110","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5101\/nbe.v14i1.p71-80","volume":"14","author":"W Chen","year":"2022","unstructured":"Chen W, Xu Y, Yang D, Wang P, Xu Y, Zhu J, et al. Preparation of Liposomes Coated Superparamagnetic Iron Oxide Nanoparticles for Targeting and Imaging Brain Glioma. Nano Biomed Eng. 2022;14:71\u201380.","journal-title":"Nano Biomed Eng"},{"key":"3198_CR111","doi-asserted-by":"publisher","first-page":"38693","DOI":"10.18632\/oncotarget.9584","volume":"7","author":"L Zhang","year":"2016","unstructured":"Zhang L, Habib AA, Zhao D. Phosphatidylserine-targeted liposome for enhanced gliomaselective imaging. Oncotarget. 2016;7:38693\u2013706.","journal-title":"Oncotarget"},{"key":"3198_CR112","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/neuonc\/nov264","volume":"18","author":"MC Fr\u00fchwald","year":"2016","unstructured":"Fr\u00fchwald MC, Biegel JA, Bourdeaut F, Roberts CWM, Chi SN. Atypical teratoid\/rhabdoid tumors - Current concepts, advances in biology, and potential future therapies. Neuro Oncol. 2016;18:764\u201378.","journal-title":"Neuro Oncol"},{"key":"3198_CR113","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1200\/JCO.20.00494","volume":"39","author":"AL Angiolillo","year":"2021","unstructured":"Angiolillo AL, Schore RJ, Kairalla JA, Devidas M, Rabin KR, Zweidler-McKay P, et al. Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children\u2019s Oncology Group AALL0932. J Clin Oncol. 2021;39:1437\u201347.","journal-title":"J Clin Oncol"},{"key":"3198_CR114","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1089\/jayao.2021.0103","volume":"11","author":"V Avutu","year":"2022","unstructured":"Avutu V, Weiss AR, Reed DR, Ahmed SK, Allen-Rhoades WA, Chen YLE, et al. Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children\u2019s Oncology Group Study ARST1321. J Adolesc Young Adult Oncol. 2022;11:328\u201332.","journal-title":"J Adolesc Young Adult Oncol"},{"key":"3198_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pbc.28439","volume":"68","author":"R Vatner","year":"2021","unstructured":"Vatner R, James CD, Sathiaseelan V, Bondra KM, Kalapurakal JA, Houghton PJ. Radiation therapy and molecular-targeted agents in preclinical testing for immunotherapy, brain tumors, and sarcomas: Opportunities and challenges. Pediatr Blood Cancer. 2021;68:1\u201311.","journal-title":"Pediatr Blood Cancer"},{"key":"3198_CR116","doi-asserted-by":"crossref","unstructured":"Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): A multicentre randomised controlled trial. Lancet Oncol. 2012;13(10):1045\u20131054.","DOI":"10.1016\/S1470-2045(12)70346-7"},{"key":"3198_CR117","first-page":"145","volume":"21","author":"SL Spunt","year":"2021","unstructured":"Spunt SL, Million L. HHS Public Access Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Patients. 2021;21:145\u201361.","journal-title":"HHS Public Access Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Patients"},{"key":"3198_CR118","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1200\/JCO.21.01628","volume":"39","author":"R Venkatramani","year":"2021","unstructured":"Venkatramani R, Xue W, Randall RL, Wolden S, Anderson J, Lopez-Terrada D, et al. Synovial Sarcoma in Children, Adolescents, and Young Adults: A Report from the Children\u2019s Oncology Group ARST0332 Study. J Clin Oncol. 2021;39:3927\u201337.","journal-title":"J Clin Oncol"},{"key":"3198_CR119","doi-asserted-by":"crossref","unstructured":"Andriyanov A V., Koren E, Barenholz Y, Goldberg SN. Therapeutic efficacy of combining PEGylated liposomal doxorubicin and radiofrequency (RF) ablation: Comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes. PLoS One.2014;9(5):e92555.","DOI":"10.1371\/journal.pone.0092555"},{"key":"3198_CR120","doi-asserted-by":"crossref","unstructured":"Noon A, Galban S. Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas. Neoplasia. 2023;40:100899.","DOI":"10.1016\/j.neo.2023.100899"},{"key":"3198_CR121","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/pbc.29044","volume":"68","author":"F Sora","year":"2021","unstructured":"Sora F, Annunziata M, Laurenti L, Giammarco S, Chiusolo P, Innocenti I, et al. Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed\/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review. Pediatr Blood Cancer. 2021;68:2\u20133.","journal-title":"Pediatr Blood Cancer"},{"key":"3198_CR122","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12879-023-07999-2","volume":"23","author":"S Niemel\u00e4","year":"2023","unstructured":"Niemel\u00e4 S, Lempinen L, L\u00f6yttyniemi E, Oksi J, Jero J. Bacterial meningitis in adults: a retrospective study among 148 patients in an 8-year period in a university hospital. Finland BMC Infect Dis. 2023;23:2\u201311. https:\/\/doi.org\/10.1186\/s12879-023-07999-2.","journal-title":"Finland. BMC Infect Dis"},{"key":"3198_CR123","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijregi.2023.03.013","volume":"7","author":"N Hovmand","year":"2023","unstructured":"Hovmand N, Lundbo LF, Kronborg G, Dars\u00f8 P, Benfield T. Factors associated with treatment delay and outcome in community acquired bacterial meningitis. IJID Reg. 2023;7:176\u201381. https:\/\/doi.org\/10.1016\/j.ijregi.2023.03.013.","journal-title":"IJID Reg"},{"key":"3198_CR124","doi-asserted-by":"crossref","unstructured":"Sharma S, Mohler J, Mahajan SD, Schwartz SA, Bruggemann L, Aalinkeel R. Microbial biofilm: A review on formation, infection, antibiotic resistance, control measures, and innovative treatment. Microorganisms. 2023;12(10):1961.","DOI":"10.3390\/microorganisms12101961"},{"key":"3198_CR125","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.2147\/IJN.S130125","volume":"12","author":"CB Garcia","year":"2017","unstructured":"Garcia CB, Shi D, Webster TJ. Tat-functionalized liposomes for the treatment of meningitis: An in vitro study. Int J Nanomedicine. 2017;12:3009\u201321. https:\/\/doi.org\/10.2147\/IJN.S130125.","journal-title":"Int J Nanomedicine"},{"key":"3198_CR126","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijantimicag.2011.10.014","volume":"39","author":"AF Gazzoni","year":"2012","unstructured":"Gazzoni AF, Capilla J, Mayayo E, Guarro J. Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis. Int J Antimicrob Agents. 2012;39:223\u20137. https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.10.014.","journal-title":"Int J Antimicrob Agents"},{"key":"3198_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules27031105","volume":"27","author":"MT Fatima","year":"2022","unstructured":"Fatima MT, Islam Z, Ahmad E, Hoque M, Yamin M. Plasma Bead Entrapped Liposomes as a Potential Drug Delivery System to Combat Fungal Infections. Molecules. 2022;27:1\u201315.","journal-title":"Molecules"},{"key":"3198_CR128","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/17476348.2021.1875821","volume":"15","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Hill AT. Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection. Expert Rev Respir Med. 2021;15:737\u201344.","journal-title":"Expert Rev Respir Med"},{"key":"3198_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.01401","volume":"10","author":"AB Scriboni","year":"2019","unstructured":"Scriboni AB, Couto VM, De Morais Ribeiro LN, Freires IA, Groppo FC, De Paula E, et al. Fusogenic liposomes increase the antimicrobial activity of vancomycin against staphylococcus aureus biofilm. Front Pharmacol. 2019;10:1\u201311.","journal-title":"Front Pharmacol"},{"key":"3198_CR130","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1473-3099(13)70078-1","volume":"13","author":"A Loyse","year":"2013","unstructured":"Loyse A, Thangaraj H, Easterbrook P, Ford N, Roy M, Chiller T, et al. Cryptococcal meningitis: Improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis. 2013;13:629\u201337. https:\/\/doi.org\/10.1016\/S1473-3099(13)70078-1.","journal-title":"Lancet Infect Dis"},{"key":"3198_CR131","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","volume":"10","author":"FB Cavassin","year":"2021","unstructured":"Cavassin FB, Ba\u00fa-Carneiro JL, Vilas-Boas RR, Queiroz-Telles F. Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections. Infect Dis Ther. 2021;10:115\u201347.","journal-title":"Infect Dis Ther"},{"key":"3198_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom9120773","volume":"9","author":"B Salehi","year":"2019","unstructured":"Salehi B, Selamoglu Z, Mileski KS, Pezzani R, Redaelli M, Cho WC, et al. Liposomal cytarabine as cancer therapy: From chemistry to medicine. Biomolecules. 2019;9:1\u201319.","journal-title":"Biomolecules"},{"key":"3198_CR133","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jocn.2011.02.026","volume":"18","author":"S Ananda","year":"2011","unstructured":"Ananda S, Nowak AK, Cher L, Dowling A, Brown C, Simes J, et al. Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy. J Clin Neurosci. 2011;18:1444\u20138. https:\/\/doi.org\/10.1016\/j.jocn.2011.02.026.","journal-title":"J Clin Neurosci"},{"key":"3198_CR134","doi-asserted-by":"crossref","unstructured":"Alrbyawi H, Poudel I, Annaji M, Boddu SHS, Arnold RD, Tiwari AK, et al. pH-sensitive liposomes for enhanced cellular uptake and cytotoxicity of daunorubicin in melanoma (B16-BL6) cell lines. Pharmaceutics. 2022;14(6):1128.","DOI":"10.3390\/pharmaceutics14061128"},{"key":"3198_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2021.634378","volume":"15","author":"J Folbergrov\u00e1","year":"2021","unstructured":"Folbergrov\u00e1 J, Je\u0161ina P, Ot\u00e1hal J. Treatment With Resveratrol Ameliorates Mitochondrial Dysfunction During the Acute Phase of Status Epilepticus in Immature Rats. Front Neurosci. 2021;15:1\u201310.","journal-title":"Front Neurosci"},{"key":"3198_CR136","doi-asserted-by":"crossref","unstructured":"Besag FM, Wallace SJ, Dulac O, Alving J, Spencer SC, Hosking G. Lamotrigine for the treatment of epilepsy in childhood. J Pediatr. 1995;127(6):991\u2013997.","DOI":"10.1016\/S0022-3476(95)70047-1"},{"key":"3198_CR137","first-page":"35","volume":"16","author":"M Erfani","year":"2022","unstructured":"Erfani M, Ashrafzadeh F, Rahimi HR, Ebrahimi SA, Kalali K, Beiraghi Toosi M, et al. Effect of Curcumin on Pediatric Intractable Epilepsy. Iran J Child Neurol. 2022;16:35\u201345.","journal-title":"Iran J Child Neurol"},{"key":"3198_CR138","first-page":"435","volume":"61","author":"RD Goldman","year":"2015","unstructured":"Goldman RD, Meckler GD. Intranasal sumatriptan for migraine in children. Can Fam Physician. 2015;61:435\u20137.","journal-title":"Can Fam Physician"},{"key":"3198_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-622","volume":"14","author":"JH Yoon","year":"2014","unstructured":"Yoon JH, Kwon MM, Park HJ, Park SY, Lim KY, Joo J, et al. A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors. BMC Cancer. 2014;14:1\u20139.","journal-title":"BMC Cancer"},{"key":"3198_CR140","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/pbc.24670","volume":"61","author":"AA Nageswara Rao","year":"2014","unstructured":"Nageswara Rao AA, Wallace DJ, Billups C, Boyett JM, Gajjar A, Packer RJ. Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: Report from the children\u2019s oncology group. Pediatr Blood Cancer. 2014;61:102\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"3198_CR141","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.bjc.6601997","volume":"91","author":"AC Verschuur","year":"2004","unstructured":"Verschuur AC, Grill J, Lelouch-Tubiana A, Couanet D, Kalifa C, Vassal G. Temozolomide in paediatric high-grade glioma: A key for combination therapy? Br J Cancer. 2004;91:425\u20139.","journal-title":"Br J Cancer"},{"key":"3198_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-020-00417-2","volume":"21","author":"C Siebel","year":"2020","unstructured":"Siebel C, W\u00fcrthwein G, Lanvers-Kaminsky C, Andr\u00e9 N, Berthold F, Castelli I, et al. Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure. BMC Pharmacol Toxicol. 2020;21:1\u201310.","journal-title":"BMC Pharmacol Toxicol"},{"key":"3198_CR143","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000100013","volume":"53","author":"CE Nath","year":"2007","unstructured":"Nath CE, McLachlan AJ, Shaw PJ, Coakley JC, Earl JW. Amphotericin B dose optimization in children with malignant diseases. Chemotherapy. 2007;53:142\u20137.","journal-title":"Chemotherapy"},{"key":"3198_CR144","doi-asserted-by":"crossref","unstructured":"Schneider F, Gessner A, El-Najjar N. Efficacy of vancomycin and meropenem in central nervous system infections in children and adults: Current update. Antibiotics (Basel). 2022;11(2):173.","DOI":"10.3390\/antibiotics11020173"},{"key":"3198_CR145","doi-asserted-by":"crossref","unstructured":"Lombardo D, Kiselev MA. Methods of liposomes preparation: Formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics. 2022;14(3):543.","DOI":"10.3390\/pharmaceutics14030543"},{"key":"3198_CR146","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8:e09394. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394.","journal-title":"Heliyon"},{"key":"3198_CR147","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40290-018-0243-9","volume":"32","author":"KS Valeur","year":"2018","unstructured":"Valeur KS, Holst H, Allegaert K. Excipients in Neonatal Medicinal Products: Never Prescribed Commonly Administered. Pharmaceut Med. 2018;32:251\u20138. https:\/\/doi.org\/10.1007\/s40290-018-0243-9.","journal-title":"Pharmaceut Med"},{"key":"3198_CR148","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/archdischild-2014-307793","volume":"100","author":"G Nellis","year":"2015","unstructured":"Nellis G, Metsvaht T, Varendi H, Toompere K, Lass J, Mesek I, et al. Potentially harmful excipients in neonatal medicines: A pan-European observational study. Arch Dis Child. 2015;100:694\u20139.","journal-title":"Arch Dis Child"},{"key":"3198_CR149","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/jac\/dkae479","volume":"80","author":"L Chiusaroli","year":"2025","unstructured":"Chiusaroli L, Barbieri E, Dell\u2019Anna L, Petris MG, Liberati C, Reggiani G, et al. Efficacy and safety of posaconazole and liposomal amphotericin B use for prophylaxis of invasive fungal infections in a paediatric and young adult haemato-oncological population. J Antimicrob Chemother. 2025;80:802\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"3198_CR150","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-3-642-20195-0_11","volume":"205","author":"M Roth-Cline","year":"2011","unstructured":"Roth-Cline M, Gerson J, Bright P, Lee CS, Nelson RM. Ethical considerations in conducting pediatric research. Handb Exp Pharmacol. 2011;205:219\u201344.","journal-title":"Handb Exp Pharmacol"},{"key":"3198_CR151","doi-asserted-by":"publisher","first-page":"29","DOI":"10.36469\/jheor.2021.21967","volume":"8","author":"RT Ballock","year":"2021","unstructured":"Ballock RT, Seif J, Goodwin R, Lin JH, Cirillo J. Clinical and economic outcomes associated with use of liposomal bupivacaine versus standard of care for management of postsurgical pain in pediatric patients undergoing spine surgery. J Heal Econ Outcomes Res. 2021;8:29\u201335.","journal-title":"J Heal Econ Outcomes Res"},{"key":"3198_CR152","doi-asserted-by":"crossref","unstructured":"Domingues C, Jarak I, Veiga F, Dourado M, Figueiras A. Pediatric drug development: Reviewing challenges and opportunities by tracking innovative therapies. Pharmaceutics. 2023;15(10):2431.","DOI":"10.3390\/pharmaceutics15102431"},{"key":"3198_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:1\u201313.","journal-title":"Front Pharmacol"},{"key":"3198_CR154","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2165\/00003088-200948040-00004","volume":"48","author":"A Peyrl","year":"2009","unstructured":"Peyrl A, Sauermann R, Traunmueller F, Azizi AA, Gruber-Olipitz M, Gupper A, et al. Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years. Clin Pharmacokinet. 2009;48:265\u201371.","journal-title":"Clin Pharmacokinet"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03198-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03198-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03198-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:36:15Z","timestamp":1758771375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03198-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":154,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3198"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03198-1","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"206"}}